Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 7/20 | 0.43 |
| ▸ | PDE10A | Q9Y233 | 9/20 | 0.41 |
| ▸ | IDH1 | O75874 | 1/20 | 0.36 |
| ▸ | IDH2 | P48735 | 1/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2554675 | 0.85 | ADORA2A (0.47) | ADORA2APDE10A | |
| SCHEMBL2551256 | 0.85 | ADORA2A (0.47) | ADORA2APDE10A | |
| SCHEMBL14672678 | 0.81 | ADORA2A (0.62) | ADORA2APDE10AEGLN1 | |
| SCHEMBL2573914 | 0.81 | ADORA2A (0.62) | ADORA2APDE10AIDH1IDH2EGLN1 | |
| SCHEMBL14717394 | 0.79 | ADORA2A (0.63) | ADORA2APDE10AEGLN1 | |
| SCHEMBL14672677 | 0.79 | ADORA2A (0.63) | ADORA2APDE10AEGLN1 | |
| SCHEMBL2548979 | 0.75 | ADORA2A (0.47) | ADORA2APDE10AIDH1IDH2 | |
| SCHEMBL2572030 | 0.69 | ADORA2A (0.60) | ADORA2APDE10AIDH1IDH2EGLN1 | |
| SCHEMBL2546203 | 0.69 | ADORA2A (0.60) | ADORA2APDE10AEGLN1 | |
| SCHEMBL2548740 | 0.68 | ADORA2A (0.70) | ADORA2APDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011121418-A1 | 4 - AMINOPYRIMIDINE DERIVATIVES AND THEIR AS AS ADENOSINE A2A RECEPTOR ANTAGONISTS | PALOBIOFARMA, S.L. (ES) | 2011-10-06 | — | — | WO | claimed |
| WO-2011121418-A1 | 4 - AMINOPYRIMIDINE DERIVATIVES AND THEIR AS AS ADENOSINE A2A RECEPTOR ANTAGONISTS | PALOBIOFARMA, S.L. (ES) | 2011-10-06 | — | — | WO | disclosed |